Jeff Yass’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $404K | Sell |
14,450
-24,327
| -63% | -$685K | ﹤0.01% | 10384 |
|
|
2026
Q1 | $1.11M | Buy |
+38,777
| New | +$1.32M | ﹤0.01% | 7613 |
|
|
2025
Q3 | – | Sell |
-66,170
| Closed | -$2.28M | – | 12345 |
|
|
2025
Q2 | $2.17M | Buy |
66,170
+682
| +1% | +$22.2K | ﹤0.01% | 5623 |
|
|
2025
Q1 | $2.11M | Buy |
65,488
+42,360
| +183% | +$1.57M | ﹤0.01% | 5409 |
|
|
2024
Q4 | $707K | Buy |
23,128
+10,744
| +87% | +$346K | ﹤0.01% | 7804 |
|
|
2024
Q3 | $347K | Buy |
+12,384
| New | +$305K | ﹤0.01% | 9283 |
|
|
2024
Q2 | – | Sell |
-76,533
| Closed | -$1.77M | – | 12005 |
|
|
2024
Q1 | $2.33M | Buy |
76,533
+31,419
| +70% | +$1.05M | ﹤0.01% | 4992 |
|
|
2023
Q4 | $1.61M | Buy |
45,114
+33,973
| +305% | +$1.26M | ﹤0.01% | 5835 |
|
|
2023
Q3 | $488K | Sell |
11,141
-28,698
| -72% | -$1.4M | ﹤0.01% | 8280 |
|
|
2023
Q2 | $1.97M | Buy |
39,839
+19,229
| +93% | +$886K | ﹤0.01% | 5199 |
|
|
2023
Q1 | $854K | Buy |
20,610
+9,815
| +91% | +$407K | ﹤0.01% | 7231 |
|
|
2022
Q4 | $479K | Sell |
10,795
-2,769
| -20% | -$116K | ﹤0.01% | 7972 |
|
|
2022
Q3 | $530K | Buy |
+13,564
| New | +$621K | ﹤0.01% | 8328 |
|
|
2022
Q1 | – | Sell |
-4,629
| Closed | -$322K | – | 12942 |
|
|
2021
Q4 | $322K | Buy |
+4,629
| New | +$336K | ﹤0.01% | 10304 |
|
|
2021
Q3 | – | Sell |
-8,199
| Closed | -$631K | – | 12709 |
|
|
2021
Q2 | $650K | Buy |
8,199
+4,337
| +112% | +$315K | ﹤0.01% | 8919 |
|
|
2021
Q1 | $253K | Sell |
3,862
-5,884
| -60% | -$362K | ﹤0.01% | 10956 |
|
|
2020
Q4 | $543K | Buy |
9,746
+4,527
| +87% | +$196K | ﹤0.01% | 8093 |
|
|
2020
Q3 | $208K | Buy |
+5,219
| New | +$221K | ﹤0.01% | 9385 |
|
|
2020
Q2 | – | Sell |
-74,772
| Closed | -$3.26M | – | 10096 |
|
|
2020
Q1 | $2.51M | Buy |
+74,772
| New | +$2.69M | ﹤0.01% | 3569 |
|
|
2019
Q4 | – | Sell |
-23,547
| Closed | -$670K | – | 9681 |
|
|
2019
Q3 | $587K | Buy |
23,547
+9,512
| +68% | +$272K | ﹤0.01% | 6925 |
|
|
2019
Q2 | $419K | Sell |
14,035
-26,840
| -66% | -$784K | ﹤0.01% | 7639 |
|
|
2019
Q1 | $1.09M | Buy |
+40,875
| New | +$1.24M | ﹤0.01% | 4868 |
|
|
2017
Q1 | – | Sell |
-69,759
| Closed | -$1.22M | – | 8907 |
|
|
2016
Q4 | $1.36M | Buy |
+69,759
| New | +$1.26M | ﹤0.01% | 4870 |
|
Other funds holding ATRC
HRCM
NAMI
Jeff Yass's ATRC Position: Q2 2026 in Review
Jeff Yass reduced its AtriCure (ATRC) stake by 63% in Q2 2026, selling an estimated $685K and leaving 14,450 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #10384.
Jeff Yass first reported a position in ATRC in Q4 2016 and has held it in 23 quarters since. The position peaked at $2.51M in Q1 2020. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Jeff Yass held 14,450 shares of AtriCure worth $404K as of Q2 2026.
- Jeff Yass sold 24,327 AtriCure shares in Q2 2026, an estimated $685K.
- AtriCure made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10384 holding.
- Jeff Yass first reported a position in AtriCure in Q4 2016 and has held it in 23 quarters since.
- Jeff Yass's AtriCure position peaked at $2.51M in Q1 2020.
- 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.